We are live on
!
Find out more
HPCM
High Pointe Capital Management Portfolio holdings
AUM
$139M
1-Year Est. Return
24.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.92%
1 Year Est. Return
+24.99%
3 Year Est. Return
+92.38%
5 Year Est. Return
+133.03%
10 Year Est. Return
–
AUM
$63.2M
AUM Growth
+$2.41M
(+4%)
Cap. Flow
-$127K
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
29.37%
Holding
85
New
10
Increased
5
Reduced
13
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.28M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$840K |
| 3 |
Medtronic
MDT
|
+$828K |
| 4 |
Whirlpool
WHR
|
+$757K |
| 5 |
Newell Brands
NWL
|
+$681K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.13M |
| 2 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$1.09M |
| 3 |
UnitedHealth
UNH
|
+$922K |
| 4 |
BHI
Baker Hughes
BHI
|
+$823K |
| 5 |
NOV
NOV
|
+$774K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.86% |
| 2 | Healthcare | 16.03% |
| 3 | Technology | 15.17% |
| 4 | Industrials | 8.2% |
| 5 | Communication Services | 7.5% |
Similar funds
COF
TC
FFA
NWM
KCA
RCM
SIS
MWM
High Pointe Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, High Pointe Capital Management held 85 positions worth $63.2M, up 4% from $60.8M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
High Pointe Capital Management's Q1 2017 filing shows 10 new, 5 increased, 13 reduced and 5 closed positions. Its largest new stake was Chevron: 11,440 shares worth $1.23M. The largest sale was Merck, an estimated $1.13M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.
- High Pointe Capital Management's largest Q1 2017 buy was Chevron: 11,440 shares worth $1.23M.
- High Pointe Capital Management added most to SLB Ltd in Q1 2017, an estimated $378K increase.
- High Pointe Capital Management's biggest Q1 2017 reduction was NOV, cutting an estimated $774K.
- High Pointe Capital Management fully exited Merck in Q1 2017, selling an estimated $1.13M.
- High Pointe Capital Management's ten largest holdings make up 29% of its $63.2M portfolio in Q1 2017.
- High Pointe Capital Management opened 10 new positions and closed 5 in Q1 2017.
- High Pointe Capital Management's portfolio value rose 4% quarter-over-quarter to $63.2M.
Based on High Pointe Capital Management's 13F filing for Q1 2017, filed 5 May 2017.